Advanced Filters
noise

Human Papilloma Virus Clinical Trials

A listing of Human Papilloma Virus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 264 clinical trials
M Manuel Fernández Sánchez, MD, PhD

International Pilot Study for Dual Non-invasive Assesment of Embryo Development

Choosing the best embryo is one of the major challenges for achieving success in in vitro fertilization (IVF). Traditionally, embryo evaluation has been based on morphological quality (how the embryo looks like) and chromosomal status as diagnosed by a genetic testing. However, recently new techniques that do not require manipulation …

20 - 42 years of age Female Phase N/A
C Caroline M Zuckerman, BS, RN

Quantifying Uterine Elastography in Menstruating Women

This study is aiming to characterize the elasticity of the female reproductive tract including the uterus, cervix and ovary using shear wave elastography at different times during the menstrual cycle and define the standard reference range of normal uterine and ovarian elasticity. By doing so, the potential of using shear …

18 - 45 years of age Female Phase N/A

Aurora Test for ART Donor Patients (AURORA-Donor)

This is a randomized observational study. The main aim is to determine potential oocyte competence predictive mRNA expression profiles in the cumulus cells isolated form individual oocytes. In 2 patient cohorts: 1)GnRH Antagonist & hr-FSH with GnRH Agonist trigger, 2) Progesterone & hr-FSH with GnRH Agonist trigger.

18 - 35 years of age Female Phase N/A

REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies)

This survey targets controlled ovarian stimulation with this drug for the development of multiple oocytes in women undergoing assisted reproduction (ART) such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

years of age Female Phase N/A
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy

Background Medical advances have improved survival rates for many cancers and other illnesses. This means that more people are coping with the long-term effects of these treatments. Some treatments can cause female infertility. Ovarian tissue cryopreservation (OTC) may help. Before undergoing a treatment that may damage their fertility, patients may …

4 - 35 years of age Female Phase N/A
H Hadas Lemberg, PhD

The Derivation of Human Embryonic Stem Cell Lines From PGD Embryos

Human embryonic stem cells (hESCs) are isolated from the early human embryo and have the capability to proliferate indefinitely in culture and to develop into nearly every cell of the human body. hESC are important for studying developmental biology and for cell replacement therapies for the treatment of degenerative human …

18 years of age All Phase N/A
B Barbara Lawrenz, PhD

Is the AMH Intrafollicular Level a Predictor of the Ploidy Status of the Blastocyst?

To investigate, whether on the day of egg retrieval, after ovarian stimulation for ICSI (intracytoplasmic sperm injection), there is a correlation between the intrafollicular AMH (Anti-Müllerian hormone) levels and the ploidy status of the blastocyst.

18 - 40 years of age Female Phase N/A
G Güzin Ünlü Suvari, Ph.D. (C)

Cyberchondria and Stress in Women Undergoing Infertility Treatment

This study examines how searching for health information on the internet may affect stress and emotional well-being in women undergoing infertility treatment. Infertility is a common condition that impacts about 48 million couples worldwide and can cause not only physical challenges but also significant emotional strain, including anxiety, depression, and …

18 - 45 years of age Female Phase N/A
A Astrid E.P. Cantineau, Dr.

Measuring Free Radicals in Human Sperm Cells Related to Microbiota and Lifestyle Factors

The cause of infertility can be due to a female factor or a male factor. In case of a male factor, it is often due to poor semen quality. However, the cause of poor quality is often unknown. In previous research, infertility problems in men were related to chemical processes …

18 - 55 years of age Male Phase N/A
S Sören von Otte, PD Dr.

Follitropin Delta in Long GnRH-agonist Protocol

The REWAG study ("Real-world Evaluation of Women undergoing Agonist protocol with Follitropin delta") is a non-interventional observational study conducted across several fertility centers in Germany. The goal of this study is to evaluate how well a personalized dosing regimen of a hormone called Follitropin delta works in women undergoing controlled …

18 - 44 years of age Female Phase N/A

Simplify language using AI